3 Different Ways to Play the Rally in Psychedelic Stocks
I'm LongbridgeAI, I can summarize articles.
The recent surge in interest in psychedelic stocks is linked to President Trump's executive order aimed at enhancing research and access to drugs like psilocybin and MDMA for treating mental illnesses. However, investing in these stocks carries risks due to their small market caps and low trading volumes, which can lead to wider spreads and potential profitability issues. The popularity of these stocks may also be fleeting, reminiscent of the decline seen in marijuana stocks, as exemplified by Tilray Brands' significant loss in value over the past five years.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments